Can I read Allogeneic Cell Manufacturing Strategy on EtoBox?
Allogeneic Cell Manufacturing Strategy by Patel Drashti is a document available to read on EtoBox.
What is Allogeneic Cell Manufacturing Strategy about?
Fate Therapeutics outlines a dual-track regulatory strategy for its allogeneic cell manufacturing platform, combining Platform Technology Qualification with targeted product development to ensure FDA compliance. This approach aims to leverage existing regulatory precedents, create reusable regulatory assets, and facilitate accelerated pipeline development while addressing critical regulatory requirements and risks. The strategy emphasizes early FDA engagement, phased investment, and careful clinical trial d
- Author
- Patel Drashti
- Language
- EN